Uranium Companies

There are very few pure uranium companies. Most companies, especially the small exploration type, are active in more than the uranium industry. This blog makes no attempt to guage the percentage of a companies activity that are related to the finding, mining or processing of uraniun. They all do, however, have some uranium activities (to the best of our review).

Merv's Uranium Indices

I have developed two Uranium Indices. They each have the same component stocks but are calculated using different methodologies. My weekly Index is based upon the average weekly performance of the component stocks. My daily Index is based upon the daily average of the component stocks open, high, low and close prices along with the daily average volume of all component stocks.

Click on the chart or table to enlage the view.

16 September 2010

Merv's Daily Commentary 16 Sept 2010

After The Close, 16 Sept 2010

Merv’s Daily Uranium Index
Market Data

Open: 168.24
High: 170.50
Low: 165.46
Close: 167.72
Volume: 3662

Note that the volume is an average volume of round lot sales for the 50 component stocks. For total volume, multiply by 5000.

A slight down day as was expected. Nothing much has changed in the indicators except that the short term momentum indicator has now moved below its overbought line and the Stochastic Oscillator is once more moving lower and is already below its level from last week. Both indicators suggest we may have a few more down days ahead. Other than that the ratings remain as in the past few days. We will probably have another down day tomorrow.

The Merv’s Daily Uranium Index closed on the down side by 0.97 points or 0.57%. There were 11 winners, 26 losers and 13 just sitting around doing nothing much. Cameco lost 0.6%, Extract lost 5.3%, Fronteer lost 0.9%, Paladin lost 1.9% and Uranium One lost 0.9%. The best winner of the da was Xemplar Energy with a gain of 33.3% while the loser of the day was Forum Uranium with a loss of 5.9%. Market vectors Nuclear Energy ETF lost 1.5%.

No comments: